NVAX Novavax
- 13.785
- -0.265-1.89%
- 13.800
- +0.015+0.11%
Novavax News
Form 144 | Novavax(NVAX.US) Director Proposes to Sell 205.65K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $Novavax(NVAX.US)$ Director YOUNG JAMES F intends to sell 15,000 shares of its common stock on Jun 18, with a total market value of approximately $205.65K. Source: A
Novavax's South African Phase IIb COVID-19 Vaccine Trial Likely to Reveal Results Within Next Fortnight, Source Says
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum
Form 144 | Novavax(NVAX.US) Officer Proposes to Sell 201.19K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Novavax(NVAX.US)$ Officer Dubovsky Filip intends to sell 13,904 shares of its common stock on Jun 17, with a total market value of approximately $201.19K. Dubovsky F
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial Company'
On CNBC's "Mad Money Lightning Round," Jim Cramer said he still can't recommend Twilio (NASDAQ:TWLO).On June 14, Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its pri
Novavax Seeks FDA Approval for Updated Covid-19 Vaccine
Fifth Times a Charm, But Just for the Nasdaq | Wall Street Today
Major stock indexes pulled back Friday, but the Nasdaq still climbed to a Fifth closing high.
Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine
Novavax (NVAX) said Friday it has filed an Emergency Use Authorization amendment to the US Food and Drug Administration for its updated JN.1 COVID-19 vaccine for individuals aged 12 and older. Novavax
Express News | Novavax Shares Down 1.5% in Volume Spike After It Seeks FDA Approval for Updated Covid Vaccine
Novavax Seeks FDA Authorization for Updated JN.1 COVID Shot
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for
Express News | FDA Says On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula): If Feasible Use KP.2 Strain Of JN.1-Lineage
Express News | Novavax - Submitted Amendment to Emergency Use Authorization to U.S. FDA for Updated Jn.1 Covid-19 Vaccine (Nvx-Cov2705) for People Aged 12 & Older
Express News | Novavax Inc: Intends to Have Its Vaccine in Pre-Filled Syringes Available in U.S. for Immediate Release Post-Authorization
Express News | Novavax Inc - Also Working With Other Regulatory Authorities Globally on Authorization or Approval of Its Jn.1 Covid-19 Vaccine
Express News | Novavax Inc - Novavax's Filing Is Aligned With FDA, EMA and Who Global Recommendations on Vaccine Composition
Express News | Novavax Inc - Novavax's Jn.1 Covid-19 Vaccine Would Be Only Protein-Based Option Available in U.S.
Express News | Novavax Inc - Intends to Have Doses in U.S. for Distribution by Mid-August
Express News | Novavax Inc - Novavax's Updated Jn.1 Covid-19 Vaccine Is Active Against Current Circulating Strains, Including Kp.2 and Kp.3
Express News | Novavax Submits Application to U.S. FDA for Updated Protein-Based 2024-2025 Formula Covid-19 Vaccine
Analysis
Price Target
No Data
